Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Negative PR-Negative HER2-Negative Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Not applicableLooking for participantsNCT06744465
What this trial is testing

NearWave Optical Molecular Monitoring

Who this might be right for
Breast CancerHER2-positive Breast CancerTNBC - Triple-Negative Breast Cancer+2 more
Indiana University 15
Testing effectiveness (Phase 2)WithdrawnNCT01953536
What this trial is testing

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Who this might be right for
Breast Neoplasms
Endocyte
Early research (Phase 1)Study completedNCT01676753
What this trial is testing

Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer

Who this might be right for
Advanced or Metastatic Breast CancerTriple Negative Breast Cancer
Jo Chien 32
Large-scale testing (Phase 3)Temporarily pausedNCT03777579
What this trial is testing

First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC

Who this might be right for
Triple Negative Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 375
Testing effectiveness (Phase 2)Study completedNCT05181462
What this trial is testing

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.

Who this might be right for
Triple Negative Breast Cancer
Cantargia AB 117
Post-approval studies (Phase 4)Looking for participantsNCT04136782
What this trial is testing

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417
What this trial is testing

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more
Immunitas Therapeutics 67
Large-scale testing (Phase 3)Active Not RecruitingNCT01674140
What this trial is testing

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 1,939
Testing effectiveness (Phase 2)Active Not RecruitingNCT06027268
What this trial is testing

Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Cancer
Wake Forest University Health Sciences 36
Testing effectiveness (Phase 2)Study completedNCT03872791
What this trial is testing

KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 52
Early research (Phase 1)Study completedNCT01846091
What this trial is testing

Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more
Mayo Clinic 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07107217
What this trial is testing

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Blokhin's Russian Cancer Research Center 40
Testing effectiveness (Phase 2)Ended earlyNCT04434560
What this trial is testing

Neoadjuvant Immunotherapy in Brain Metastases

Who this might be right for
Brain Metastases, Adult
Sarah Sammons, MD 1
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)UnknownNCT02607215
What this trial is testing

Platinum Rechallenge in Patients With Platinum-sensitive mTNBC

Who this might be right for
Metastatic Breast Cancer
Fudan University 84
Not applicableLooking for participantsNCT05037825
What this trial is testing

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Who this might be right for
Non-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell Carcinoma+1 more
VastBiome 800
Not applicableLooking for participantsNCT06281210
What this trial is testing

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
European Institute of Oncology 77
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407517
What this trial is testing

Adjuvant Intensification for LAR

Who this might be right for
Breast Cancer FemalesTriple Negative Breast Cancer (TNBC)
Fudan University 904
Not applicableLooking for participantsNCT04959474
What this trial is testing

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage 2 Breast Cancer AJCC v8+4 more
Thomas Jefferson University 80
Next Page